• Malignant neoplasm of anus and anal canal
  • Low Density Lipoprotein (LDL, VLDL)
  • Biopsy, Liver
  • Cortisol, Salivary
  • Coxsackie B (1-6) Antibodies, (CSF)
  • Hydrocodone and Metabolites, Urine
  • Lower gastrointestinal hemorrhage
  • Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™)
  • FLG (filaggrin) Gene Mutation Analysis
  • Beta-2 Glycoprotein 1 Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Diseases (2)
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...